Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,075.00    0.00 (0.00%)
Bid:
5,080.00
Ask:
5,095.00
Spread: 15.00 (0.295%)
Market Cap: $1.33t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Decision on Share Disposition

26 Jan 2026 07:00

RNS Number : 3314Q
Samsung Electronics Co. Ld
26 January 2026
 

Decision on Share Disposition

 

1. Number of shares to be disposed

Common

1,152,022

Other

-

2. Price of shares to be disposed (Korean won)

Common

152,100

Other

-

3. Value of shares to be disposed (Korean won)

Common

175,222,546,200

Other

-

4. Expected disposition period

Start date

January 26, 2026

End date

January 26, 2026

5. Purpose of disposition

Use of treasury shares as performance based compensation to executives and other employees

6. Method of disposition

Open-market (shares)

-

After-hours block trades (shares)

-

Off-market (shares)

-

Other (shares)

1,152,022

7. Counterparties to the disposition

YoungHyun Jun and 1,050 others

8. Consignment investment brokers

Samsung Securities Co., Ltd.

Shinhan Securities Co., Ltd.

KB Securities Co., Ltd.

9. Holding status of treasury shares before disposition

Disposition within the allowable distribution of profit (shares)

Common

109,126,021

Ratio (%)

1.8

Other

13,603,461

Ratio (%)

1.7

Other disposition (shares)

Common

-

Ratio (%)

-

Other

-

Ratio (%)

-

10. Date of board resolution (confirmation date)

January 23, 2026

- Attendance of Independent Directors at the Board of Directors meeting

Present

6

Absent

0

- Attendance of Auditors (Audit Committee members who are not Independent Directors)

-

11. Daily sell order quantity limit

Common

-

Other

-

 

 

 

 

 

12. Other Information to Consider:

- This disclosure relates to the use of treasury shares in the agreed amount as part of the 2024 OPI to strengthen responsible management by executives, etc., and motivate long-term value creation. The conditions for the grant and the number of recipients are as follows:

[Grant conditions] The agreed number of shares will be granted based on the market price at the time of payment (January 2026)

[Number of persons eligible for grant] 1,051

- The above details are subject to change within the scope approved by the Board, depending on the number of recipients at the time of the grant and changes in the stock price

- In Item 2 above, the price of shares to be disposed (Korean won) is based on the closing price on the day of the Board's resolution (January 23, 2026)

- In Item 3 above, the value of shares to be disposed (Korean won) was calculated by multiplying the number of shares to be disposed by the closing price on the day of board resolution. The actual amount may change depending on stock price at the time of disposal.

- In Item 6 above, the method of disposition involves the transfer from the company's treasury account to the accounts of designated employees

- In Item 10 above, all Audit Committee members are Independent Directors (all Audit Committee members were in attendance)

- In Item 11 above, the daily sell order quantity limit is not applicable, as the shares will not be sold through on-market transaction on the securities market

- Holding status of treasury shares before purchase

(Number of shares)

Stock type

Initial quantity

Changes

End quantity

Purchase

Disposal

Cancellation

Common

91,828,987

17,297,034

-

-

109,126,021

Other

13,603,461

-

-

-

13,603,461

- The 'Initial quantity' represents the number of shares held on as of January 1, 2026, the first day of the fiscal year in which the disclosure document was prepared; and the 'End quantity' refers to the number of shares held on January 23, 2026, the day the disclosure document was prepared.

 

 

 

 

 

 

Additional disclosure items

1. Relationship with the Company or its controlling shareholder by disclosure counterparty

- Executives, etc., of the Company subject to the 2024 performance incentive share agreement

2. Reason for selecting the disposal counterparty

- To strengthen responsible management and motivate long-term value creation, the Company agreed to grant shares as part of the 2024 performance incentive compensation and the conditions for share delivery have been met.

3. Number of shares to be disposed by counterparty

- 1,152,022 common shares

4. Basis for price determination

  - The price of shares to be disposed in Item 2 and the value of shares to be disposed in Item 3 were calculated based on the closing price on the day of the Board's resolution (January 23, 2026). However, the stock price and the actual amount may change depending on future stock price movements.

5. Expected Dilutive Effect on Share Value

- The number of shares to be disposed in Item 1 above represent approximately 0.019% of the total number of issued shares (5,919,637,922 common), and the dilutive effect on share value is expected to be insignificant

6. Other matters to consider for investment

 - Of the 1,152,022 shares to be disposed, the number of shares subject to selling restrictions is as follows:

166,136 shares subject to a two-year selling restriction

847,528 shares subject to a one-year selling restriction

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUACGUPQUQQ
Date   Source Headline
31st Oct 20249:02 amRNSDelisting and Listing of Stocks
31st Oct 20247:00 amRNSQuarterly Dividend for Third Quarter 2024
31st Oct 20247:00 amRNS2024 3Q Earnings Release
31st Oct 20247:00 amRNSAnnouncement of Capex Plan for FY2024
8th Oct 20247:00 amRNSNotice of 3Q 2024 Earning Release
8th Oct 20247:00 amRNS3Q 2024 Pre-Earnings Guidance
30th Aug 202410:52 amRNS2024 Half-year Business Report
31st Jul 20249:33 amRNSTransaction with Affiliate Company
31st Jul 20249:26 amRNSCharitable Contribution
31st Jul 20247:00 amRNSQuarterly Dividend for Second Quarter 2024
31st Jul 20247:00 amRNS2024 2Q Earnings Release
5th Jul 20247:55 amRNSNotice of 2Q 2024 Earnings Release Schedule
5th Jul 20247:45 amRNS2Q 2024 Pre-Earnings Guidance
28th Jun 20248:53 amRNSSustainability Report 2024
31st May 202410:23 amRNSCorporate Governance Report FY2023
31st May 20247:00 amRNS2024 1Q INTERIM BUSINESS REPORT
21st May 20249:34 amRNSNotice on Change of CEO
30th Apr 20248:10 amRNSTransactions with Affiliated Companies
30th Apr 20247:00 amRNSQuarterly Dividend for First Quarter 2024
30th Apr 20247:00 amRNS2024 1Q Earnings Release
30th Apr 20247:00 amRNS2023 Business Report
5th Apr 20247:11 amRNSNotice of 1Q 2024 Earnings Release Schedule
5th Apr 20247:00 amRNS1Q 2024 Pre-Earnings Guidance
20th Mar 20249:07 amRNSTransactions with Affiliated Companies
20th Mar 20249:05 amRNSResults of the 55th Annual General Meeting
21st Feb 20247:00 amRNSReference Material for 2024 AGM
20th Feb 20248:31 amRNSCharitable Contribution
19th Feb 20249:40 amRNS2023 Separate Financial Statements
19th Feb 20249:34 amRNS2023 Consolidated Financial Statements
31st Jan 20247:00 amRNSYear-End Dividend for FY2023
31st Jan 20247:00 amRNS2023 4Q Earning Release
31st Jan 20247:00 amRNSTransactions with Affiliated Companies
31st Jan 20247:00 amRNSShareholder Return Program for FY2024-2026
31st Jan 20247:00 amRNSAnnouncement of Capex Result for FY2023
9th Jan 20247:00 amRNSNotice of 4Q 2023 Earning Release
9th Jan 20247:00 amRNS4Q 2023 Pre-Earnings Guidance
1st Dec 202311:09 amRNSCharitable Contribution
30th Nov 20237:54 amRNSTransactions with Affiliated Companies
30th Nov 20237:34 amRNS2023 3Q Interim Business Report
6th Nov 20238:43 amRNSAnnouncement of Investor Relations Event
31st Oct 20237:21 amRNSTransactions with Affiliated Companies
31st Oct 20237:18 amRNSAnnouncement of Capex Plan for FY2023
31st Oct 20237:13 amRNSQuarterly Dividend for Third Quarter 2023
31st Oct 20237:10 amRNS2023 3Q Earning Release
11th Oct 20237:10 amRNSNotice of 3Q 2023 Earning Release
11th Oct 20237:04 amRNS3Q 2023 Pre-Earnings Guidance
21st Sep 20237:30 amRNS2022 Business Report
21st Sep 20237:29 amRNS2022 Separate Financial Statements
21st Sep 20237:29 amRNS2022 Consolidated Financial Statements
31st Aug 20238:15 amRNS2023 Half-year Business Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.